Allogene Therapeutics, Inc (ALLO) Stock Price

1.23 ▼ -0.06 (-4.65%)
Open: 1.31 Vol: 3.63M Day's range: 1.2101 - 1.3292 Jun 20, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALLO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.23▼ 1.24▼ 1.25▼ 1.31▼ 1.24▼
MA10 1.23▼ 1.26▼ 1.27▼ 1.37▼ 1.32▼
MA20 1.24▼ 1.28▼ 1.30▼ 1.28▼ 1.55▼
MA50 1.26▼ 1.32▼ 1.36▼ 1.33▼ 2.09▼
MA100 1.28▼ 1.37▼ 1.36▼ 1.56▼ 2.76▼
MA200 1.31▼ 1.34▼ 1.23▼ 2.00▼ 6.82▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.000▼ -0.005▼ -0.007▼ -0.001▼ 0.008▲
RSI 33.677▼ 28.226▼ 28.443▼ 44.088▼ 40.596▼
STOCH 20.000     11.586▼ 18.074▼ 30.495     38.469    
WILL %R -75.000     -90.909▼ -92.857▼ -82.090▼ -66.183    
CCI -60.705     -110.650▼ -152.409▼ -113.947▼ -46.566    
Latest Filters Detected On ALLO
▼ MACD $ALLO MACD(12,26,9) Crossed Below Signal Line Set Alert
MA $ALLO Price Crossed Below MA(26) Set Alert
▼ BREAK $ALLO Price Breaks 10 Days Low Set Alert
CDL $ALLO Engulfing Candlestick Pattern Detected Set Alert
Allogene Therapeutics, Inc News
Why Is Allogene Therapeutics (ALLO) Up 52.2% Since Last Earnings Report?
Thursday, June 12, 2025 08:30 AM
A month has gone by since the last earnings report for Allogene Therapeutics (ALLO). Shares have added about 52.2% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
Allogene Therapeutics Presents Promising Phase 1 Data for ALLO-316 in Renal Cell Carcinoma
Monday, June 02, 2025 12:26 PM
Allogene Therapeutics Inc. (NASDAQ:ALLO) presented updated data from the Phase 1 TRAVERSE study of ALLO-316 in advanced or metastatic renal cell carcinoma/RCC during an oral presentation at the 2025 ...
Allogene Therapeutics Highlights Promising Phase 1 Results of ALLO-316 in Advanced Renal Cell Carcinoma at ASCO 2025
Sunday, June 01, 2025 07:50 AM
June 01, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T ) products for cancer ...
ALLO historical stock data
date open high low close volume
20/06/25 1.31 1.3292 1.2101 1.23 3,630,549
18/06/25 1.29 1.36 1.26 1.29 2,123,957
17/06/25 1.35 1.39 1.29 1.30 1,667,801
16/06/25 1.35 1.41 1.3204 1.37 1,764,080
13/06/25 1.35 1.4186 1.325 1.34 2,450,471
12/06/25 1.43 1.45 1.3801 1.40 2,282,726
11/06/25 1.49 1.50 1.44 1.45 2,594,726
10/06/25 1.39 1.505 1.39 1.47 2,019,331
09/06/25 1.45 1.50 1.37 1.41 2,214,437
06/06/25 1.30 1.47 1.29 1.42 3,475,881
Quote Details
52wk Low:0.862
52wk High:3.78
Vol:3.63M
Avg Vol(3m):58.8M
1Y Chng:-45.09%
1M Chng:+4.24%
Add to Watch List
More Information
Index US Composite
Market Cap. 269.04M